Nyvepria Dosage
Generic name: PEGFILGRASTIM 6mg in 0.6mL
Dosage form: injection, solution
Drug class: Colony stimulating factors
Medically reviewed by Drugs.com. Last updated on Jun 29, 2023.
Patients with Cancer Receiving Myelosuppressive Chemotherapy
The recommended dosage of NYVEPRIA is a single subcutaneous injection of 6 mg administered once per chemotherapy cycle. For dosing in pediatric patients weighing less than 45 kg, refer to Table 1. Do not administer NYVEPRIA between 14 days before and 24 hours after administration of cytotoxic chemotherapy.
Administration
NYVEPRIA is administered subcutaneously via a single-dose prefilled syringe for manual use.
Prior to use‚ remove the carton from the refrigerator and allow the NYVEPRIA prefilled syringe to reach room temperature for a minimum of 30 minutes. Discard any prefilled syringe left at room temperature for greater than 15 days.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. NYVEPRIA is supplied as a clear and colorless solution. Do not administer NYVEPRIA if discoloration or particulates are observed.
The NYVEPRIA syringe plunger stopper and needle cover are not made with natural rubber latex.
Pediatric Patients Weighing Less than 45 kg
The NYVEPRIA prefilled syringe is not designed to allow for direct administration of doses less than 0.6 mL (6 mg). The syringe does not bear graduation marks, which are necessary to accurately measure doses of NYVEPRIA less than 0.6 mL (6 mg) for direct administration to patients. Thus, the direct administration to patients requiring dosing of less than 0.6 mL (6 mg) is not recommended due to the potential for dosing errors. Refer to Table 1.
| Body Weight | NYVEPRIA Dose | Volume to Administer |
|---|---|---|
|
||
|
Less than 10 kg* |
See below* |
See below* |
|
10 – 20 kg |
1.5 mg |
0.15 mL |
|
21 – 30 kg |
2.5 mg |
0.25 mL |
|
31 – 44 kg |
4 mg |
0.4 mL |
Frequently asked questions
- What are biosimilar drugs and how do they compare to biologics?
- What does cbqv stand for in pegfilgrastim?
- What biosimilars have been approved in the United States?
- What is the difference between Fulphila and Neulasta?
- What is the difference between Udenyca and Neulasta?
- How is Fulphila injected / administered?
- Is Fulphila a chemo drug?
- What is the difference between Udenyca and Fulphila?
More about Nyvepria (pegfilgrastim)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- Drug class: colony stimulating factors
- En español
Patient resources
- Nyvepria drug information
- Nyvepria (Pegfilgrastim Subcutaneous) (Advanced Reading)
- Nyvepria (Pegfilgrastim-apgf Subcutaneous) (Advanced Reading)
Other brands
Neulasta, Fulphila, Udenyca, Stimufend, ... +2 more
Professional resources
Other brands
Neulasta, Fulphila, Udenyca, Stimufend, ... +2 more
Related treatment guides
See also:
Augmentin
Augmentin is a prescription antibiotic combining amoxicillin and clavulanate to treat bacterial ...
Zosyn
Zosyn is used to treat bacterial infections such as urinary tract and skin infections and ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Zarxio
Zarxio (filgrastim-sndz) is biosimilar product used to treat neutropenia associated with ...
Neulasta
Neulasta is used to stimulate neutrophil growth and reduce infection risk (manifested by febrile ...
Neupogen
Neupogen (filgrastim) is used to treat neutropenia, a lack of certain white blood cells caused by ...
Nivestym
Nivestym is used for bone marrow transplantation, neutropenia, neutropenia associated with ...
Gentamicin
Gentamicin systemic is used for bacteremia, bacterial endocarditis prevention, bacterial infection ...
Piperacillin/tazobactam
Piperacillin/tazobactam systemic is used for appendectomy, appendicitis, aspiration pneumonia ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
